Review: Magnetic Resonance Spectroscopy Studies of Pediatric Major Depressive Disorder
Author(s) -
Douglas G. Kondo,
Tracy Hellem,
Young-Hoon Sung,
Namkug Kim,
Eun-Kee Jeong,
Kristen K. Delmastro,
Xianfeng Shi,
Perry F. Renshaw
Publication year - 2010
Publication title -
depression research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 27
eISSN - 2090-133X
pISSN - 2090-1321
DOI - 10.1155/2011/650450
Subject(s) - major depressive disorder , neurochemical , medicine , pathophysiology , depression (economics) , psychiatry , clinical psychology , mood , economics , macroeconomics
. This paper focuses on the application of Magnetic Resonance Spectroscopy (MRS) to the study of Major Depressive Disorder (MDD) in children and adolescents. Method . A literature search using the National Institutes of Health's PubMed database was conducted to identify indexed peer-reviewed MRS studies in pediatric patients with MDD. Results . The literature search yielded 18 articles reporting original MRS data in pediatric MDD. Neurochemical alterations in Choline, Glutamate, and N-Acetyl Aspartate are associated with pediatric MDD, suggesting pathophysiologic continuity with adult MDD. Conclusions . The MRS literature in pediatric MDD is modest but growing. In studies that are methodologically comparable, the results have been consistent. Because it offers a noninvasive and repeatable measurement of relevant in vivo brain chemistry, MRS has the potential to provide insights into the pathophysiology of MDD as well as the mediators and moderators of treatment response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom